Home LiteratureArticle Details
PMID: 1693014 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Blocking of the initiation-to-elongation transition by a transdominant RNA polymerase mutation.

Science (New York, N.Y.) ·Vol. 248 ·No. 4958 ·1990-05-25 ·Pages 1006-9

Kashlev M, Lee J, Zalenskaya K, Nikiforov V, Goldfarb A

Abstract

RNA polymerase, the principal enzyme of gene expression, possesses structural features conserved in evolution. A substitution of an evolutionarily invariant amino acid (Lys1065----Arg) in the beta subunit of Escherichia coli RNA polymerase apparently disrupts its catalytic center. The mutant protein inhibited cell growth when expressed from an inducible promoter. The assembled holoenzyme carrying the mutant subunit formed stable promoter complexes that continuously synthesized promoter-specific dinucleotides but that did not enter the elongation step. The mutant polymerase inhibited transcription by blocking the access of the wild-type enzyme to promoters.

MeSH Terms
Amino Acid Sequence DNA Mutational Analysis DNA-Directed RNA Polymerases/genetics,metabolism Escherichia coli/enzymology,genetics Genes, Dominant Molecular Sequence Data Promoter Regions, Genetic RNA/biosynthesis Structure-Activity Relationship
Chemicals
RNA DNA-Directed RNA Polymerases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kashlev M
Institute of Molecular Genetics, U.S.S.R. Academy of Sciences, Moscow.
Lee J
Zalenskaya K
Nikiforov V
Goldfarb A
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1990-05-25
Pages
1006-9
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Grants
NIGMS NIH HHS · GM30717 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com